Geert Leroux-Roels

Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins

Lennart Martens, Marion Koopmans, Elien Vandermarliere, 2018, Scientific Reports.

Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity

James S. Owen, Joe Grove, Peter Balfe, 2007, Journal of Virology.

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials.

Pierre Vandepapelière, Jeanne-Marie Devaster, G. Leroux-Roels, 2015, Vaccine.

Unmet needs in modern vaccinology: adjuvants to improve the immune response.

G. Leroux-Roels, Geert Leroux-Roels, 2010, Vaccine.

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

C. Rice, B. Lindenbach, R. Lanford, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.

A. Folgori, R. Cortese, A. Nicosia, 2012, Journal of hepatology.

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults

R. A. van den Berg, Margherita Coccia, Erik Jongert, 2018, Front. Immunol..

Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1*

Martine De Vos, Roosmarijn E. Vandenbroucke, Nick Devoogdt, 2014, The Journal of Biological Chemistry.

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

G. Leroux-Roels, M. Seiberling, Geert Leroux-Roels, 2008, Vaccine.